QIAGEN Expands QIAstat-Dx Operations with New Barcelona Site
QIAGEN is relocating its QIAstat-Dx operations to a new facility in Barcelona to strengthen its syndromic testing capabilities.
Read MorePosted by Andy Lundin | Dec 2, 2024 | Company News |
QIAGEN is relocating its QIAstat-Dx operations to a new facility in Barcelona to strengthen its syndromic testing capabilities.
Read MorePosted by Andy Lundin | Nov 22, 2024 | Emerging & Zoonotic Diseases |
Researchers developed an advanced diagnostic kit enabling rapid detection and differentiation of H5N1 avian influenza strains.
Read MorePosted by Andy Lundin | Nov 19, 2024 | Point-of-Care, Sample Storage & Management |
Fluxergy is collaborating with NIAID to enhance molecular testing and sample preparation on its innovative platform.
Read MorePosted by Andy Lundin | Nov 14, 2024 | Emerging & Zoonotic Diseases |
Researchers developed an optical biosensor that rapidly identifies mpox, enabling quicker, more accessible diagnoses at the point of care.
Read MorePosted by Andy Lundin | Nov 12, 2024 | Sequencing Systems |
A mNGS test offers a rapid, comprehensive solution to diagnose a broad range of pathogens in neurological and respiratory infections.
Read More